135 related articles for article (PubMed ID: 19405385)
1. Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain.
Kuhad A; Bishnoi M; Chopra K
Indian J Exp Biol; 2009 Mar; 47(3):193-7. PubMed ID: 19405385
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine attenuates thermal hyperalgesia through 5-HT1/2 receptors in streptozotocin-induced diabetic mice.
Anjaneyulu M; Chopra K
Eur J Pharmacol; 2004 Aug; 497(3):285-92. PubMed ID: 15336946
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents.
Jones CK; Peters SC; Shannon HE
J Pharmacol Exp Ther; 2005 Feb; 312(2):726-32. PubMed ID: 15494550
[TBL] [Abstract][Full Text] [Related]
4. Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain.
Kuhad A; Sharma S; Chopra K
Eur J Pain; 2008 Jul; 12(5):624-32. PubMed ID: 18055235
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
Wernicke JF; Pritchett YL; D'Souza DN; Waninger A; Tran P; Iyengar S; Raskin J
Neurology; 2006 Oct; 67(8):1411-20. PubMed ID: 17060567
[TBL] [Abstract][Full Text] [Related]
6. Impaired noradrenaline homeostasis in rats with painful diabetic neuropathy as a target of duloxetine analgesia.
Kinoshita J; Takahashi Y; Watabe AM; Utsunomiya K; Kato F
Mol Pain; 2013 Nov; 9():59. PubMed ID: 24279796
[TBL] [Abstract][Full Text] [Related]
7. A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy.
Mixcoatl-Zecuatl T; Jolivalt CG
Br J Pharmacol; 2011 Sep; 164(1):159-69. PubMed ID: 21410686
[TBL] [Abstract][Full Text] [Related]
8. AS1069562, the (+)-isomer of indeloxazine, but not duloxetine has a curative-like analgesic effect in a rat model of streptozotocin-induced diabetic neuropathy.
Murai N; Aoki T; Tamura S; Yamamoto H; Hamakawa N; Matsuoka N
Neuropharmacology; 2014 Apr; 79():10-6. PubMed ID: 24211301
[TBL] [Abstract][Full Text] [Related]
9. Long-term administration of fluvoxamine attenuates neuropathic pain and involvement of spinal serotonin receptors in diabetic model rats.
Kato T; Kajiyama S; Hamada H; Kawamoto M
Hiroshima J Med Sci; 2013 Dec; 62(4):83-9. PubMed ID: 24597211
[TBL] [Abstract][Full Text] [Related]
10. Review of duloxetine in the management of diabetic peripheral neuropathic pain.
Smith T; Nicholson RA
Vasc Health Risk Manag; 2007; 3(6):833-44. PubMed ID: 18200804
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
Westanmo AD; Gayken J; Haight R
Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
[TBL] [Abstract][Full Text] [Related]
12. 5-HT7 receptor activation attenuates thermal hyperalgesia in streptozocin-induced diabetic mice.
Ulugol A; Oltulu C; Gunduz O; Citak C; Carrara R; Shaqaqi MR; Sanchez AM; Dogrul A
Pharmacol Biochem Behav; 2012 Aug; 102(2):344-8. PubMed ID: 22609798
[TBL] [Abstract][Full Text] [Related]
13. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
Christoph T; De Vry J; Tzschentke TM
Neurosci Lett; 2010 Feb; 470(2):91-4. PubMed ID: 20026182
[TBL] [Abstract][Full Text] [Related]
14. The analgesia effect of duloxetine on post-operative pain via intrathecal or intraperitoneal administration.
Sun YH; Li HS; Zhu C; Hu W; Yang J; Zhao GL; Lu GJ; Wu SX; Dong YL
Neurosci Lett; 2014 May; 568():6-11. PubMed ID: 24686187
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine vs. placebo in patients with painful diabetic neuropathy.
Goldstein DJ; Lu Y; Detke MJ; Lee TC; Iyengar S
Pain; 2005 Jul; 116(1-2):109-18. PubMed ID: 15927394
[TBL] [Abstract][Full Text] [Related]
16. Spinal Serotonin and 5HT6 Receptor Levels During Development of Neuropathy and Influence of Blockade of these Receptors on Thermal Hyperalgesia in Diabetic Mice.
Sari CC; Gunduz O; Ulugol A
Drug Res (Stuttg); 2019 Aug; 69(8):428-433. PubMed ID: 30609433
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine in diabetic neuropathy.
Smith TR
Expert Opin Pharmacother; 2006 Feb; 7(2):215-23. PubMed ID: 16433585
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the analgesic effects of ammoxetine, a novel potent serotonin and norepinephrine reuptake inhibitor.
Zhang TT; Xue R; Zhu L; Li J; Fan QY; Zhong BH; Li YF; Ye CY; Zhang YZ
Acta Pharmacol Sin; 2016 Sep; 37(9):1154-65. PubMed ID: 27424654
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of duloxetine in the treatment of chronic daily headache].
Artemenko AR; Kurenkov AL; Filatova EG
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(8):24-8. PubMed ID: 18379468
[TBL] [Abstract][Full Text] [Related]
20. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain.
Sharma S; Kulkarni SK; Agrewala JN; Chopra K
Eur J Pharmacol; 2006 May; 536(3):256-61. PubMed ID: 16584726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
